Real-time enrollment status for this hypercholesterolemia clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 9:55 AM UTC
| NCT Number | NCT06451770 |
| Recruiting Status | Recruiting |
| Condition | Hypercholesterolemia |
| Phase | PHASE1 |
| Target Enrollment | 36 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Verve Therapeutics, Inc. |
| Last Updated on CT.gov | July 17, 2026 (Jul 17, 2026) |
As of October 13, 2026: Clinical trial NCT06451770 is currently recruiting participants. This phase1 study for hypercholesterolemia is actively seeking new participants at 4 locations across the United States. The study is sponsored by Verve Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06451770 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06451770 was last updated Jul 17, 2026 (July 17, 2026). HelloStudys verifies this status automatically.